메뉴 건너뛰기




Volumn 879, Issue 1, 2011, Pages 95-99

Quantification of meclizine in human plasma by high performance liquid chromatography-mass spectrometry

Author keywords

Liquid chromatography; Mass spectrometry; Meclizine; Pharmacokinetics

Indexed keywords

AGILENT; ANALYTICAL TOOL; ASSAY METHODS; CLINICAL PHARMACOKINETICS; COEFFICIENT OF VARIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRIES; HUMAN PLASMAS; HUMAN SUBJECTS; INTER-DAY VARIATIONS; INTERNAL STANDARDS; LINEAR CALIBRATION CURVE; LOWER LIMIT OF QUANTIFICATIONS; MECLIZINE; MOBILE PHASE; MOTION SICKNESS; MULTIPLE REACTION MONITORING; PHARMACOKINETIC STUDIES; POSITIVE ELECTROSPRAY IONIZATION; PROTEIN PRECIPITATION; REPRODUCIBILITIES; SPECTROMETRIC METHODS; STORAGE CONDITION;

EID: 78650518129     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.11.022     Document Type: Article
Times cited : (19)

References (10)
  • 9
    • 0038296381 scopus 로고    scopus 로고
    • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)
    • FDA Guidance for Industry Bioanalytical Method Validation 2001, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
    • (2001) FDA Guidance for Industry Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.